ArticleBMC infectious diseases2021

Ruxolitinib versus dexamethasone in hospitalized adults with COVID-19: multicenter matched cohort study.

O V Stanevich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.